Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation
- PMID: 16116870
Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation
Abstract
Background and aim of the study: The study aim was to evaluate the effect of percutaneous balloon mitral valvuloplasty (PBMV) on plasma B-type natriuretic peptide (BNP) levels in patients in sinus rhythm (SR) and with atrial fibrillation (AF).
Methods: Thirty patients with rheumatic mitral stenosis who underwent successful PBMV were included in the study. Of these patents, 21 were in SR (SR group) and nine had AF (AF group). Plasma BNP levels were measured using the Triage BNP Test in all patients before, and at 20 min and 24 h after, PBMV. Control levels were measured in eight healthy volunteers.
Results: Basal plasma BNP levels in patients were significantly higher than those in controls (123.5 +/- 69.5 versus 16.4 +/- 7.6 pg/ml, p < 0.01), and correlated with mean left atrial pressure (mLAP; r = 0.441, p < 0.05) and pulmonary artery pressure (PAP; r = 0.488, p < 0.01). No significant difference was observed in BNP levels between the SR and AF groups. In the SR group, BNP levels decreased after PBMV (pre-PBMV 128.7 +/- 75.9 pg/ml; at 20 min, 88.6 +/- 62.0 pg/ml; at 24 h, 43.4 +/- 26.7 pg/ml; respectively, p < 0.05). Changes in plasma BNP (deltaBNP) correlated positively with those in mLAP (deltamLAP) (r = 0.696, p < 0.01) and PAP (deltaPAP) (r = 0.456, p < 0.05). Left ventricular end-diastolic volume (LVEDV) (96.1 +/- 21.6 versus 111.5 +/- 25.2 ml, p < 0.01) and stroke volume (SV) (59.2 +/- 15.8 versus 69.0 +/- 17.9 ml, p < 0.05) augmented accordingly without any changes in left ventricular end-diastolic pressure (LVEDP) (p = NS). In contrast, in group AF, BNP levels remained unchanged (pre-PBMV 111.6 +/- 53.4 pg/ml; at 20 min, 122.0 +/- 68.7 pg/ml; at 24 h, 106.1 +/- 56.2 pg/ml; respectively, p = NS), while LVEDP increased (6.4 +/- 3.6 versus 8.6 +/- 3.2 mmHg, p < 0.01), without any changes in LVEDV and SV (p = NS).
Conclusion: The study results indicate that, in mitral stenosis patients, a high BNP level is associated with high mLAP and PAP. Cardiac rhythm may play an important role in changes of BNP level after PBMV. BNP may be a valid marker to reflect changes in mLAP and PAP after PBMV in patients with SR, but not in those with AF.
Similar articles
-
Neurohormones in mitral stenosis before and after percutaneous balloon mitral valvotomy.J Heart Valve Dis. 2002 Mar;11(2):185-90. J Heart Valve Dis. 2002. PMID: 12000158
-
Decreased plasma brain natriuretic peptide levels after a successful maze procedure.J Heart Valve Dis. 2003 May;12(3):287-91. J Heart Valve Dis. 2003. PMID: 12803326
-
Percutaneous transvenous mitral commissurotomy: hemodynamic and initial outcome differences between atrial fibrillation and sinus rhythm in rheumatic mitral stenosis patients.J Med Assoc Thai. 2001 May;84(5):674-80. J Med Assoc Thai. 2001. PMID: 11560217
-
Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.Circulation. 2004 Jul 13;110(2):124-7. doi: 10.1161/01.CIR.0000134481.24511.BC. Epub 2004 Jun 21. Circulation. 2004. PMID: 15210589 Review.
-
Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients.Minerva Cardioangiol. 2004 Dec;52(6):479-89. Minerva Cardioangiol. 2004. PMID: 15729209 Review.
Cited by
-
Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.Glob Heart. 2020 May 18;15(1):38. doi: 10.5334/gh.807. Glob Heart. 2020. PMID: 32923332 Free PMC article. Review.
-
Higher Copeptin Levels are Associated with the Risk of Atrial Fibrillation in Patients with Rheumatic Mitral Stenosis.Acta Cardiol Sin. 2021 Jul;37(4):412-419. doi: 10.6515/ACS.202107_37(4).20210111A. Acta Cardiol Sin. 2021. PMID: 34257491 Free PMC article.
-
Changes in Serum NT-Pro BNP and Left Atrial BNP Levels after Percutaneous Transvenous Mitral Commissurotomy in Sinus Rhythm Versus Atrial Firilation.J Cardiovasc Thorac Res. 2014;6(3):175-9. doi: 10.15171/jcvtr.2014.007. Epub 2014 Sep 30. J Cardiovasc Thorac Res. 2014. PMID: 25320665 Free PMC article.
-
N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy.J Saudi Heart Assoc. 2016 Apr;28(2):81-8. doi: 10.1016/j.jsha.2015.07.002. Epub 2015 Jul 18. J Saudi Heart Assoc. 2016. PMID: 27053897 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous